Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Hypertensinogen
2. Proangiotensin
3. Renin Substrate
4. Renin Substrate Tetradecapeptide
5. Renin-substrate
6. Serpin A8
7. Serpina8
8. Tetradecapeptide, Renin Substrate
1. 64315-16-8
2. Angiotensinogen (1-14), Porcine
3. Renin Substrate Tetradecapeptide Porcine, >=97% (hplc)
4. Angiotensinogen From Porcine Plasma, Lyophilized Powder, 1,500-3,000 Units/g Protein
| Molecular Weight | 1759.0 g/mol |
|---|---|
| Molecular Formula | C85H123N21O20 |
| XLogP3 | 0.8 |
| Hydrogen Bond Donor Count | 23 |
| Hydrogen Bond Acceptor Count | 24 |
| Rotatable Bond Count | 52 |
| Exact Mass | 1757.92532540 g/mol |
| Monoisotopic Mass | 1757.92532540 g/mol |
| Topological Polar Surface Area | 650 Ų |
| Heavy Atom Count | 126 |
| Formal Charge | 0 |
| Complexity | 3610 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 15 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Serine Proteinase Inhibitors
Exogenous or endogenous compounds which inhibit SERINE ENDOPEPTIDASES. (See all compounds classified as Serine Proteinase Inhibitors.)
ABOUT THIS PAGE
A Angiotensinogen manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Angiotensinogen, including repackagers and relabelers. The FDA regulates Angiotensinogen manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Angiotensinogen API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Angiotensinogen supplier is an individual or a company that provides Angiotensinogen active pharmaceutical ingredient (API) or Angiotensinogen finished formulations upon request. The Angiotensinogen suppliers may include Angiotensinogen API manufacturers, exporters, distributors and traders.
click here to find a list of Angiotensinogen suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Angiotensinogen DMF (Drug Master File) is a document detailing the whole manufacturing process of Angiotensinogen active pharmaceutical ingredient (API) in detail. Different forms of Angiotensinogen DMFs exist exist since differing nations have different regulations, such as Angiotensinogen USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Angiotensinogen DMF submitted to regulatory agencies in the US is known as a USDMF. Angiotensinogen USDMF includes data on Angiotensinogen's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Angiotensinogen USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Angiotensinogen suppliers with USDMF on PharmaCompass.
Angiotensinogen Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Angiotensinogen GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Angiotensinogen GMP manufacturer or Angiotensinogen GMP API supplier for your needs.
A Angiotensinogen CoA (Certificate of Analysis) is a formal document that attests to Angiotensinogen's compliance with Angiotensinogen specifications and serves as a tool for batch-level quality control.
Angiotensinogen CoA mostly includes findings from lab analyses of a specific batch. For each Angiotensinogen CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Angiotensinogen may be tested according to a variety of international standards, such as European Pharmacopoeia (Angiotensinogen EP), Angiotensinogen JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Angiotensinogen USP).
LOOKING FOR A SUPPLIER?
